Press Releases
  • Ra Medical Systems Granted Broad Patent for DABRA Catheter for Cardiovascular Disease Treatment

    Catheter’s Liquid Fill with Solid Window Surface Provides Improved Tissue Removal, Contributing to DABRA’s 95 Percent Success Rate CARLSBAD, CA. – July 17, 2017 Ra Medical Systems, makers of excimer lasers and catheters for cardiovascular and dermatological diseases, today announced that the United States Patent and Trademark Office (USPTO) has Read More...

  • Ra Medical Systems Names Maurice Buchbinder, M.D., and Martin Colombatto to Board of Directors

    Carlsbad, CA – July 11, 2017 Following the €1.9 billion ($2.16 billion) purchase of The Spectranetics Corporation (NASDAQ:SPNC) by Royal Philips (NYSE:PHG), Ra Medical Systems, makers of cardiovascular and dermatology catheters and excimer lasers, today announced the appointment of two new members to the Company’s Board of Directors. This also Read More...

  • Doctor Begins First Commercial, FDA-Cleared, in Patient Use to Treat Peripheral Artery

    San Antonio, TX -  June 20, 2017 Today, the Heart Endovascular & Rhythm of Texas announced its latest collaboration with Ra Medical Systems, makers of cardiovascular and dermatology catheters and excimer lasers, to use its groundbreaking DABRA™ System for the treatment of Peripheral Artery Disease (PAD) in order to combat Read More...

  • Ra Medical Systems’ DABRA Begins First Commercial, FDA-Cleared, In-Patient Use

    New Orleans, LA—June 1, 2017 (BUSINESS WIRE) Ra Medical Systems, makers of cardiovascular and dermatology catheters and excimer lasers, today announced the commercial launch in the United States of the Company’s groundbreaking DABRA™ System for the treatment of Peripheral Artery Disease. This follows FDA clearance earlier this week. Dr. Athar Read More...

  • Ra Medical Systems Achieves FDA Clearance For Peripheral Artery Disease Treatment

    The FDA has granted marketing clearance to Ra Medical Systems for its DABRA System for peripheral artery disease treatment. The device is a catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels. The single-use catheter produces a lumen while minimizing trauma Read More...

  • FDA Grants Market Clearance to Ra Medical Systems for New Peripheral Artery Disease Treatment

    Media Contacts Caitlin Kasunich / Lisa Lipson KCSA Strategic Communications 212.896.1241 / 508.843.6428 [email protected] / [email protected] Investor Contacts Jeffrey Kraws President, Ra Medical Systems 609.306.2274 [email protected] Game- Changing DABRA System Removes Blockages from Arteries to Save Limbs and Lives CARLSBAD, Calif. – May 30, 2017 – In an effort to Read More...

  • Ra Medical Systems’ DABRA Atherectomy System Launched in Northern Europe

    April 12, 2017 Ra Medical Systems, a maker of excimer lasers and catheters for cardiovascular diseases as well as dermatological diseases, and Bo Medical Technologies, a multinational medical device sales and service distributor, recently announced the launch of the DABRA atherectomy system in Europe. In October 2016, Ra Medical announced Read More...

  • Ra Medical Systems Launches Cardiovascular and Dermatology Catheters and Lasers in Northern Europe

    Carlsbad, CA—April 6, 2017 (BUSINESS WIRE) Ra Medical Systems, makers of excimer lasers and catheters for cardiovascular and dermatological diseases, and bo medical technologies, a multinational medical device sales and service distributor, announce the launch of the DABRA Atherectomy System for cardiovascular and Pharos Excimer Laser for dermatology in Europe. Read More...

2017Previous Years